News Archive

Located in Rockville town center, ReveraGen is a fast-growing clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. We run under a venture philanthropy model, through collaborations and partnerships with non-profit foundations and government agencies in both the US and the EU. We are currently looking for self-motived professionals to join our young, energetic and diverse team.

Position Open: Project Coordinator

Main Duties:

• Takes responsibility and manages defined projects
• Keeps track of and coordinates projects by follow up on tasks and results, tracking and recordingthe projects’ progress by proper tools and software, and reports deviations back to the VicePresident of Operations.
• Creates, revises and implements standard operating procedures
• Produces information by transcribing, formatting, inputting, editing, retrieving, copying, andtransmitting text, data, and graphics.
• Represents the the Vice President of Operations in the absence of the Vice President ofOperations.
• Protects operations by keeping information confidential.

Requirements:

• Pharmaceutical or clinical research background preferred
• Excellent communication skills (both oral and written)
• B.S. or B.A. Degree required
• Familiar with Microsoft Office software package (Outlook, PowerPoint, Word, Excel)
• Smartsheet knowledge/experience is a plus

– Winner to be announced during 2017 BioHealth Capital Region Forum – 

ROCKVILLE, MARYLAND, April 11, 2017 – Five companies have been selected to present in front of a panel of judges consisting of industry leaders during the 2017 BioHealth Capital Region Forum, April 19-20 at the MedImmune campus in Gaithersburg, Maryland. Founded by BioHealth Innovation, Inc. (BHI) and MedImmune in 2016, the Crab Trap Competition focuses on companies in therapeutics, diagnostics, medical devices, healthcare services, e-health, mobile health, electronic medical records, health informatics, and biohealth cyber security. The grand prize this year is $10,000, incubation space in either Prince William County, VA or Montgomery Country, MD, and business mentoring. The 2^nd Annual Crab Trap Competition is sponsored by Wilson Sonsini Goodrich & Rosati. Last year’s winner of the Crab Trap Competition was Sonavex, Inc., a Johns Hopkins University spin-off simplifying point-of-care ultrasound imaging to increase its utility.

With the push to encourage researchers to take steps to commercialize their discoveries, there are grants and awards and tech transfer offices and incubators and competitions and…

But receiving money doesn’t automatically mean that a successful business will appear right away. Like all startups, they need to identify the potential market for a product, and come up with a plan.

With the county’s proximity to the nation’s capital and the federal government, combined with our highly educated workforce, Montgomery County is rapidly growing as a global cybersecurity power hub.

The MCEDC board has identified cybersecurity as a target industry, and commissioned a 2017 report called “Building a Cybersecurity Industry in Montgomery County.”

Standing to address a crowd of biotech business leaders and health experts at a conference hosted by Virginia’s biotechnology association this week, Inova Center for Personalized Health CEO Todd Stottlemyer began with a question.

As with many new fields, synthetic biology—which incorporates disparate disciplines like engineering, computer science, biotechnology, and molecular biology—is hard to pin down. But a rough working definition says that it is the application of the principles of engineering to biological systems. Instead of using engineering’s discrete modules of code, transistors, resistors, and capacitors, synthetic biology builds things from sequences of genetic material. The field has remarkable potential and has already been used to aid the production of antimalarial drugs and synthetic flavorings. One researcher used mail-order DNA and a genetic map available online for free to create a live polio virus. The implications could be enormous.

BioHealth Innovation, Inc. (BHI), a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland, has been awarded a renewal of its contract to extend and expand its entrepreneur-in-residence (EIR) program with the National Institutes of Health (NIH). BHI will place EIRs within the National Heart, Lung and Blood Institute (NHLBI), the NIH Office of the Director and other NIH Institutes and Centers.

Unicorns pranced all over Twitter Sunday as users celebrated an imaginary holiday for an imaginary creature. But some Twitter folk weren’t in the mood for make-believe. 

After all, who needs unicorns when majestic, spear-headed animals actually exist?

It’s not the current product lineups that matter the most for big pharma companies. It’s their pipelines.

Three big pharma companies boasting the strongest pipelines are Johnson & Johnson (NYSE: JNJ), Novartis (NYSE: NVS), and Roche (NASDAQOTH: RHHBY). Here’s what sets these drugmakers apart from their peers.

Standing to address a crowd of biotech business leaders and health experts at a conference hosted by Virginia’s biotechnology association this week, Inova Center for Personalized Health CEO Todd Stottlemyer began with a question.